Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Shilpa Gupta
Alliance for Clinical Trials in Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
275 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cross Cancer Institute
Edmonton, Alberta, Canada
- University Health Network-Princess Margaret Hospital
Toronto, Ontario, Canada
- Allan Blair Cancer Centre
Regina, Saskatchewan, Canada
- Saskatoon Cancer Centre
Saskatoon, Saskatchewan, Canada
- Mayo Clinic Hospital in Arizona
Phoenix, Arizona, United States
- Sutter Auburn Faith Hospital
Auburn, California, United States
- Alta Bates Summit Medical Center-Herrick Campus
Berkeley, California, United States
- Palo Alto Medical Foundation-Fremont
Fremont, California, United States
- Memorial Medical Center
Modesto, California, United States
- Palo Alto Medical Foundation-Camino Division
Mountain View, California, United States
- Palo Alto Medical Foundation Health Care
Palo Alto, California, United States
- Sutter Roseville Medical Center
Roseville, California, United States
- Sutter Medical Center Sacramento
Sacramento, California, United States
- University of California Davis Comprehensive Cancer Center
Sacramento, California, United States
- California Pacific Medical Center-Pacific Campus
San Francisco, California, United States
- Palo Alto Medical Foundation-Santa Cruz
Santa Cruz, California, United States
- Palo Alto Medical Foundation-Sunnyvale
Sunnyvale, California, United States
- Sutter Solano Medical Center/cancer Center
Vallejo, California, United States
- Beebe South Coastal Health Campus
Millville, Delaware, United States
- Helen F Graham Cancer Center
Newark, Delaware, United States
- Medical Oncology Hematology Consultants Pa
Newark, Delaware, United States
- Beebe Health Campus
Rehoboth Beach, Delaware, United States
- Medstar Washington Hospital Center
Washington D.C., District of Columbia, United States
- Uf Health Cancer Institute - Gainesville
Gainesville, Florida, United States
- Mayo Clinic in Florida
Jacksonville, Florida, United States
- Cleveland Clinic-Weston
Weston, Florida, United States
- Rush-Copley Medical Center
Aurora, Illinois, United States
- Advocate Good Shepherd Hospital
Barrington, Illinois, United States
- Illinois Cancercare-Bloomington
Bloomington, Illinois, United States
- Illinois Cancercare-Canton
Canton, Illinois, United States
- Illinois Cancercare-Carthage
Carthage, Illinois, United States
- Centralia Oncology Clinic
Centralia, Illinois, United States
- Advocate Illinois Masonic Medical Center
Chicago, Illinois, United States
- Northwestern University
Chicago, Illinois, United States
- Rush Md Anderson Cancer Center
Chicago, Illinois, United States
- University of Illinois
Chicago, Illinois, United States
- Amg Crystal Lake - Oncology
Crystal Lake, Illinois, United States
- Carle at the Riverfront
Danville, Illinois, United States
- Northwestern Medicine Cancer Center Kishwaukee
DeKalb, Illinois, United States
- Cancer Care Specialists of Illinois - Decatur
Decatur, Illinois, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 3 Jun 2022
- Primary completion
- 15 Jul 2029
- Completion
- 15 Jul 2029
- Last update posted
- 12 Jun 2026
- Registered enrollment
- 654
- Registry id
- NCT05092958
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.